Prior Use of Leflunomide Increases the Hazard Ratio of Discontinuation of Infliximab in a Canadian Open Label Prospective Study with Overall Drop-out Rates Similar to Other Biologic Therapies for the Treatment of Rheumatoid Arthritis Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Faraawi, Rafat
  • Hack, Frank
  • Bensen, William
  • Choquette, Denis
  • Rahman, Proton

publication date

  • November 1, 2009